KYNAMRO REMS | KYNAMRO REMS Program
KYNAMRO Risk Evaluation and Mitigation Strategy (REMS) is an FDA-required program to educate healthcare providers and patients in order to ensure that KYNAMRO is prescribed only to patients for whom the benefits outweigh the risks.
Kynamro REMS program, Kynamro mipomersen sodium, Kynamro risk information, Kynamro REMS enrollment, HoFH, homozygous FH, homozygous familial hypercholesterolemia, homozygous hypercholesterolemia, physician training, Kynamro prescribing information
Is this your site? Certify your site and update informations
